Business Trends– category –
-
Polpharma Biologics and Tuteur Forge Alliance to Boost Biosimilar Access Across Latin America
Morningstar ポーランド Overview Polpharma Biologics has finalized a strategic licensing agreement with Argentina's Tuteur Pharmaceutical, granting exclusive commercialization rights for a biosimilar targeting autoimmune diseases across L... -
Wave Life Sciences Reports Positive RNA Editing Clinical Data for WVE-006 in Alpha-1 Antitrypsin Deficiency (AATD)
BioPharm International USA Overview Wave Life Sciences announced favorable clinical data from the RestorAATion-2 trial of WVE-006, an RNA editing therapeutic for Alpha-1 Antitrypsin Deficiency (AATD). WVE-006, a GalNAc-conjugated RNA edi... -
Eli Lilly Acquires Engage Biologics for Up to $202 Million to Strengthen Non-Viral DNA Delivery Platform
GuruFocus USA Overview Eli Lilly has agreed to acquire Engage Biologics for up to $202 million, aiming to leverage Engage’s innovative non-viral DNA delivery platform and accelerate the development of next-generation gene therapies. Enga... -
Immunai and AstraZeneca Expand Oncology AI Partnership for Third Time, Valued at Up To $37.5 Million
WTWH Media USA Overview Immunai, a startup building foundation models for the human immune system, has announced a third expansion of its oncology partnership with AstraZeneca, entitling Immunai to up to $37.5 million through 2027. This ... -
CIBF2026 Highlights China’s Solid-State Battery Advances Amid Persistent Mass Production Challenges
Shanghai Metals Market (SMM) China Overview A report from CIBF2026 reveals significant progress in China's solid-state battery sector, alongside ongoing hurdles for mass production. Pure Lithium New Energy has established a 500 MWh produ... -
Advancing Cancer Therapy: siRNA Nanoparticle Delivery Strategies and Clinical Progress
MDPI Switzerland Overview This review details strategic approaches for siRNA nanoparticle delivery and outlines advancements in their clinical application for tumor therapy. Nanotechnology offers a technical pathway to boost siRNA delive... -
Translational Progress in Lipid Nanoparticle Drug Delivery Systems for Cancer Therapy: Current Status and Future Horizons
PMC (PubMed Central) International Overview This review article comprehensively examines lipid nanoparticles (LNPs) as highly adaptable nanocarrier systems for cancer therapy and diagnostics. LNPs leverage structural flexibility, biocomp... -
Vertex Pharmaceuticals Secures CASGEVY Reimbursement Agreement in Germany for Sickle Cell Disease and Beta Thalassemia
Vertex Pharmaceuticals USA Overview Vertex Pharmaceuticals announced a reimbursement agreement in Germany for CASGEVY (exa-cel), a groundbreaking gene-editing therapy for sickle cell disease (SCD) and transfusion-dependent beta thalassem... -
iPSC-Derived Retinal Sheet Transplantation for Retinitis Pigmentosa: Clinical Trial Validates Long-Term Safety and Engraftment
臨床研究等提出・公開システム (jRCT) Japan Overview A pioneering clinical study (jRCTa050200027) conducted by Kobe City Eye Center Hospital has concluded, affirming the long-term safety and engraftment of allogeneic iPSC-derived retinal s... -
The In Vivo CAR-T Race Heats Up: Big Pharma Acquisitions and Astellas’ Strategic Collaborations Signal a New Era in Cancer Therapy
Answers（アンサーズ） Japan Overview The global race to develop 'in vivo CAR-T therapy,' which generates CAR-T cells directly within the patient's body, is intensely accelerating as major pharmaceutical companies invest heavily. This inn...
